User talk:Ashhealth33

June 2020

Hello, I'm Materialscientist. I noticed that you made a change to an article, Indian Immunologicals Limited, but you didn't provide a source. I’ve removed it for now, but if you’d like to include a citation to a reliable source and re-add it, please do so! If you think I made a mistake, or if you have any questions, you can leave me a message on my talk page. Thanks. Materialscientist (talk) 04:46, 2 June 2020 (UTC)

Please do not add or significantly change content without citing verifiable and reliable sources, as you did with this edit to Indian Immunologicals Limited. Before making any potentially controversial edits, it is recommended that you discuss them first on the article's talk page. Please review the guidelines at Wikipedia:Citing sources and take this opportunity to add references to the article. Materialscientist (talk) 06:20, 2 June 2020 (UTC)

Managing a conflict of interest

Hello, Infocusrx. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about on Wikipedia, you may have a conflict of interest (COI). Editors with a conflict of interest may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:

• avoid editing or creating articles about yourself, your family, friends, colleagues, company, organization or competitors;
• propose changes on the talk pages of affected articles (you can use the {{request edit}} template);
• disclose your conflict of interest when discussing affected articles (see Wikipedia:Conflict of interest#How to disclose a COI);
• avoid linking to your organization's website in other articles (see WP:Spam);
• do your best to comply with Wikipedia's content policies.

In addition, you are required by the Wikimedia Foundation's terms of use to disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation. See Wikipedia:Paid-contribution disclosure.

Also, editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. Thank you. Guy (help!) 11:11, 3 June 2020 (UTC)

Editing/ Adding the content in the Indian Immunologicals Limited Page

IIL started manufacturing human vaccines in 1998 on a specific request by the Government of India. IIL launched purified vero cell rabies vaccine (PVRV)– Abhayrab. This led to the discontinuation of use of older and unsafe sheep brain derived vaccine (also termed Nerve Tissue Vaccine – NTV) in the country.IIL is also a major supplier of DPT, TT and Hepatitis B vaccines to India’s large Universal Immunization Programme. It is noted for developing veterinary and human vaccines for foot-and-mouth disease, rabies, bacterial vaccines, canine vaccines, hepatitis, measles, MMR vaccine and DPT vaccine. It offers Foot-and-mouth disease vaccines to farmers.

Animal Health

IIL manufactures animal health vaccines and formulations. After the introduction of FMD vaccine — “Raksha”, IIL launched the tissue culture rabies vaccine “Raksharab” in 1989. Subsequently, IIL developed vaccines through its own R & D efforts and launched them in the Indian market.

Human Biological Institute

IIL has a manufacturing facility at Ooty, Tamilnadu which produces Rabies vaccine using Vero cell line as a substrate for human use. The Human Biologicals Institute at Ooty is located at Kozhipannai village approximately five Km from Ooty town. This facility contains Production labs, Quality control lab, Warehouse, Animal testing facility and Utilities block. The design and construction of the plant meets Schedule M and cGMP guidelines. The production area is classified into unrestricted and restricted area. Unrestricted Area contains Cell culture laboratory, Media production lab, Purification lab and Formulation & filling, Packing and Manufacturing services. No live virus is handled in the unrestricted area. This area is designed as per the GMP with the provision of change rooms and equipped with HVAC for the maintenance of the class and differential air pressure etc. The restricted area contains Virus seed production lab, Antigen production, Concentration and inactivation, in- process quality control and Manufacturing Services. The entire restricted area is maintained under negative pressure and differential air pressure maintained through HVAC system.

International Business

IIL exports its products to more than 45 countries across the world with a customer focus in Middle East, Asia Pacific Region, Africa, Latin America, Russia and CIS countries. IIL is also working towards expanding the business arch towards South American market, USA and Europe.

Research & Development and Product Pipeline

The R&D efforts of Indian Immunologicals Ltd. are noticed on the development of products for the control of infectious diseases. Novel vaccines against animal diseases continue to be a major focus area for the R&D. In animal health, IIL is working on inactivated vaccine against IBR, a recombinant tick vaccine and multi component clostridial vaccine. On the human vaccines side, the R&D group has developed technology for Hepatitis A, Chikungunya vaccine, Measles rubella vaccine which are under clinical trials. Apart from this, work is on to develop the Zika Virus vaccine and Pneumococcal vaccine.

Recent Developments

The company has also acquired 50 acres of land in Biotech Park – Phase III near Karkapatla to locate its new manufacturing facilities for animal vaccines (Brucella RB 51 and other bacterial vaccines), animal health formulations and human rabies and Pentavalent vaccines. This facility has begun commercial production of animal health formulations and became fully operational for other products from mid of 2014. Immunologicals Limited (IIL) is developing a vaccine for coronavirus in a cross-continental collaboration.It is leading the cross-continental research collaboration in association with the Griffith University of Australia to develop 'live attenuated SARS-CoV-2 Vaccine or Covid-19 vaccine' using the latest codon de-optimization technology.

Veterinary and human vaccine manufacturer Indian Immunologicals Ltd. (IIL) has launched Classical Swine Fever (CSF) vaccine under brand name “Rakhsa Class” The Raksha Class vaccine is a live attenuated vaccine and has been tested for safety, sterility and potency. The field trials were conducted at Bengaluru and Hyderabad Veterinary colleges.

Infocusrx (talk) 04:51, 9 June 2020 (UTC)

Your username

Welcome to Wikipedia. I noticed that your username, "Infocusrx", may not comply with our username policy. Please note that you may not use a username that represents the name of a company, group, organization, product, service, or website. Examples of usernames that are not allowed include "XYZ Company", "MyWidgetsUSA.com", and "Foobar Museum of Art". However, you are permitted to use a username that contains such a name if it identifies you individually, such as "Sara Smith at XYZ Company", "Mark at WidgetsUSA", or "FoobarFan87".

Please also note that Wikipedia does not allow accounts to be shared by multiple people, and that you may not advocate for or promote any company, group, organization, product, service, or website, regardless of your username. Please also read our paid editing policy and our conflict of interest guideline. If you are a single individual and are willing to contribute to Wikipedia in an unbiased manner, please request a change of username, by completing the form at Special:GlobalRenameRequest, choosing a username that complies with our username policy. If you believe that your username does not violate our policy, please leave a note here explaining why. If this account represents the medical writing company InfocusRx (www.infocusrx.com), you will not be allowed to use this as your account name. Drm310 🍁 (talk) 22:45, 9 June 2020 (UTC)

Orphaned non-free image File:Indian Immunologicals Limited.png

⚠

Thanks for uploading File:Indian Immunologicals Limited.png. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).

Note that any non-free images not used in any articles will be deleted after seven days, as described in section F5 of the criteria for speedy deletion. Thank you. --B-bot (talk) 17:56, 16 June 2020 (UTC)